112 related articles for article (PubMed ID: 15968563)
1. Measuring health-related utility: why the disparity between EQ-5D and SF-6D?
Bryan S; Longworth L
Eur J Health Econ; 2005 Sep; 6(3):253-60. PubMed ID: 15968563
[TBL] [Abstract][Full Text] [Related]
2. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
Whitehurst DG; Norman R; Brazier JE; Viney R
Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
[TBL] [Abstract][Full Text] [Related]
3. An empirical comparison of EQ-5D and SF-6D in liver transplant patients.
Longworth L; Bryan S
Health Econ; 2003 Dec; 12(12):1061-7. PubMed ID: 14673814
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.
van Stel HF; Buskens E
Health Qual Life Outcomes; 2006 Mar; 4():20. PubMed ID: 16563170
[TBL] [Abstract][Full Text] [Related]
5. Unchained melody: revisiting the estimation of SF-6D values.
Craig BM
Eur J Health Econ; 2016 Sep; 17(7):865-73. PubMed ID: 26359242
[TBL] [Abstract][Full Text] [Related]
6. Quality-adjusted life expectancies in patients with rheumatoid arthritis--comparison of index scores from EQ-5D, 15D, and SF-6D.
Sørensen J; Linde L; Ostergaard M; Hetland ML
Value Health; 2012; 15(2):334-9. PubMed ID: 22433765
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
Xie F; Li SC; Luo N; Lo NN; Yeo SJ; Yang KY; Fong KY; Thumboo J
Arthritis Rheum; 2007 Aug; 57(6):1043-9. PubMed ID: 17665466
[TBL] [Abstract][Full Text] [Related]
8. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
9. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD).
Gerhards SA; Huibers MJ; Theunissen KA; de Graaf LE; Widdershoven GA; Evers SM
Value Health; 2011; 14(5):732-9. PubMed ID: 21839412
[TBL] [Abstract][Full Text] [Related]
10. EQ-5D versus SF-12 in coronary patients: are they interchangeable?
De Smedt D; Clays E; Annemans L; De Bacquer D
Value Health; 2014; 17(1):84-9. PubMed ID: 24438721
[TBL] [Abstract][Full Text] [Related]
11. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
[TBL] [Abstract][Full Text] [Related]
12. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
[TBL] [Abstract][Full Text] [Related]
13. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
Petrou S; Hockley C
Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B
J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
[TBL] [Abstract][Full Text] [Related]
15. Interchangeability of the EQ-5D and the SF-6D in long-lasting low back pain.
Søgaard R; Christensen FB; Videbaek TS; Bünger C; Christiansen T
Value Health; 2009 Jun; 12(4):606-12. PubMed ID: 19900258
[TBL] [Abstract][Full Text] [Related]
16. How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?
Boonen A; van der Heijde D; Landewé R; van Tubergen A; Mielants H; Dougados M; van der Linden S
Ann Rheum Dis; 2007 Jun; 66(6):771-7. PubMed ID: 17213254
[TBL] [Abstract][Full Text] [Related]
17. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.
Marra CA; Woolcott JC; Kopec JA; Shojania K; Offer R; Brazier JE; Esdaile JM; Anis AH
Soc Sci Med; 2005 Apr; 60(7):1571-82. PubMed ID: 15652688
[TBL] [Abstract][Full Text] [Related]
18. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population.
Bharmal M; Thomas J
Value Health; 2006; 9(4):262-71. PubMed ID: 16903996
[TBL] [Abstract][Full Text] [Related]
19. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
[TBL] [Abstract][Full Text] [Related]
20. Preference weights for the spectrum of alcohol use in the U.S. Population.
Chavez LJ; Bradley K; Tefft N; Liu CF; Hebert P; Devine B
Drug Alcohol Depend; 2016 Apr; 161():206-13. PubMed ID: 26900145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
